Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,146 public trials 6,477 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia

NCT05640102

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • South Alabama Medical Science Foundation Mitchell Cancer Institute Mobile, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Los Angeles Cancer Network (Lacn) Glendale, California, United States
View Trial Details
Recruiting

A Study of DM005 in Patients With Advanced Solid Tumors

NCT06515990

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +14 more
Locations
  • Henry Ford Cancer Institute Detroit, Michigan, United States
  • Sarah Cannon Research Institute at Mary Crowley Dallas, Texas, United States
  • NEXT Oncology Virginia Fairfax, Virginia, United States
  • Chris O'Brien Lifehouse Camperdown, New South Wales, Australia
View Trial Details
Recruiting

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

NCT05646316

Conditions
Carcinosarcoma, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations
  • George Washington University Medical Center Washington D.C., District of Columbia, United States
  • UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
  • UM Sylvester Comprehensive Cancer Center at Doral Doral, Florida, United States
View all 60 locations
View Trial Details
Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

NCT04752722

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +16 more
Locations
  • The University of Alabama at Birmingham Clinical Research Unit (CRU) Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Urological Associates of South Arizona Tucson, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
View all 102 locations
View Trial Details

Related conditions